FBIO
Fortress Biotech, Inc.
2.60
USD
This page is just a preview of the data found in TrendSpider’s full version
Fortress Biotech, Inc. stock is up 9.24% since 30 days ago. The next earnings date is Mar 28, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 53.85% of the previous 12 December’s closed higher than November. 100% of analysts rate it a buy.
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also develops late stage product candidates such as intravenous Tramadol for the treatment of post-operative acute pain.
